TCI Wealth Advisors’s Altimmune ALT Stock Holding History

TCI Wealth Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-166	Closed	-$701	–	287
2023 Q1	$701	Hold	166	–	–	﹤0.01%	2163
2022 Q4	$2.73K	Buy	+166	New	+$1.86K	﹤0.01%	1896
2020 Q4	–	Sell	-34	Closed	–	–	1531
2020 Q3	$0	Hold	34	–	–	﹤0.01%	1523
2020 Q2	$0	Hold	34	–	–	﹤0.01%	1449
2020 Q1	$0	Hold	34	–	–	﹤0.01%	1450
2019 Q4	$0	Buy	+34	New	+$63	﹤0.01%	1523

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TCI Wealth Advisors's ALT Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Altimmune (ALT) in Q2 2023, closing a stake of 166 shares — an estimated $701 sold.

TCI Wealth Advisors first reported a position in ALT in Q4 2019 and held it in 6 quarters. The position peaked at $2.73K in Q4 2022. 120 funds tracked by Wall St. Rank hold ALT as of Q2 2023.

TCI Wealth Advisors reported no remaining Altimmune position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 166 Altimmune shares in Q2 2023, an estimated $701.
TCI Wealth Advisors first reported a position in Altimmune in Q4 2019 and held it in 6 quarters.
TCI Wealth Advisors's Altimmune position peaked at $2.73K in Q4 2022.
120 funds tracked by Wall St. Rank held Altimmune as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.